Inhibitors | Comment | Organism | Structure |
---|---|---|---|
arylomycin A-C16 | secretion of proteins HtrA, PrsA, and SAOUHSC_01761 is induced by inhibitor treatment | Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | - |
- |
- |
Staphylococcus aureus NCTC 8325 | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
lipoteichoic acid synthase + H2O | - |
Staphylococcus aureus | ? | soluble C-terminal domain has a noncanonical, internal cleavage site | ? | |
lipoteichoic acid synthase + H2O | - |
Staphylococcus aureus NCTC 8325 | ? | soluble C-terminal domain has a noncanonical, internal cleavage site | ? | |
additional information | identification of 46 proteins whose extracellular accumulation requires signal peptidase activity. Forty-four possess identifiable Sec-type signal peptides and thus are likely canonically secreted proteins, while four also appear to possess cell wall retention signals. For three proteins, HtrA, PrsA, and SAOUHSC_01761, secretion is induced by inhibitor arylomycin treatment | Staphylococcus aureus | ? | - |
? | |
additional information | identification of 46 proteins whose extracellular accumulation requires signal peptidase activity. Forty-four possess identifiable Sec-type signal peptides and thus are likely canonically secreted proteins, while four also appear to possess cell wall retention signals. For three proteins, HtrA, PrsA, and SAOUHSC_01761, secretion is induced by inhibitor arylomycin treatment | Staphylococcus aureus NCTC 8325 | ? | - |
? | |
O-acetyltransferase + H2O | - |
Staphylococcus aureus | ? | soluble C-terminal domain has a noncanonical, internal cleavage site | ? | |
O-acetyltransferase + H2O | - |
Staphylococcus aureus NCTC 8325 | ? | soluble C-terminal domain has a noncanonical, internal cleavage site | ? |